phase II study

You have access
Prospective Phase II Trial of Second-line FOLFIRI in Patients with Advanced Colorectal Cancer Including Analysis of UGT1A1 Polymorphisms: FLIGHT 2 Study
KEIJI HIRATA, NAOKI NAGATA, TAKESHI KATO, YUSUKE OKUYAMA, HIDEAKI ANDOH, KENICHI TAKAHASHI, KOJI OBA, JUNICHI SAKAMOTO, SHOICHI HAZAMA and HIDEYUKI MISHIMA

Anticancer Research January 2014, 34 (1) 195-201;
You have access
Combination Phase II Study of Weekly Paclitaxel and 5’-DFUR for Unresectable or Recurrent Gastric Cancer
SHIGEFUMI YOSHINO, TAKUMI FURUYA, RYOICHI SHIMIZU, HIROAKI OZASA, TAKU NISHIMURA, SHINTARO FUKUDA, TORU KAWAOKA, SHOICHI HAZAMA and MASAAKI OKA

Anticancer Research June 2013, 33 (6) 2629-2633;
You have access
A Trial of Autologous Ex vivo-expanded NK Cell-enriched Lymphocytes with Docetaxel in Patients with Advanced Non-small Cell Lung Cancer as Second- or Third-line Treatment: Phase IIa Study
YOUNG JUN YANG, JI CHAN PARK, HOON KYO KIM, JIN HYOUNG KANG and SUK YOUNG PARK

Anticancer Research May 2013, 33 (5) 2115-2122;
You have access
Phase II Study of Bevacizumab and Temsirolimus Combination Therapy for Recurrent Glioblastoma Multiforme
ULRIK LASSEN, MORTEN SORENSEN, TINE BERNHARDTSEN GAZIEL, BENEDIKTE HASSELBALCH and HANS SKOVGAARD POULSEN

Anticancer Research April 2013, 33 (4) 1657-1660;
You have access
Combination Chemotherapy of Alternating Etoposide and Carboplatin with Weekly Administration of Irinotecan and Cisplatin in Extensive-stage Small-cell Lung Cancer
AKINOBU YOSHIMURA, RINTARO NORO, AKIHIKO MIYANAGA, HIDEAKI MIZUTANI, SEIJI KOSAIHIRA, YUJI MINEGISHI, MASAHIRO SEIKE, MITSUNORI HINO, MASAHIRO ANDO, KOICHIRO NOMURA, TETSUYA OKANO, KUNIHIKO KOBAYASHI, AKIHIKO GEMMA and THE EAST JAPAN CHESTERS GROUP

Anticancer Research October 2012, 32 (10) 4473-4478;

Main menu

User menu

Search

phase II study

Pages